Table 1. Demographics, comorbidities, and treatment.
| All patients | NIHSS>10 | NIHSS≤10 | p-value | BASIS+ | BASIS− | p-value | ASPECTS+ | ASPECTS- | p-value | |
| n | 649 | 188 | 461 | n/a | 249 | 400 | n/a | 121 | 528 | n/a |
| Age (mean±SD) | 68.2±15.4 | 69.5±16.6 | 67.8±15.0 | 0.11 | 68.2±16.8 | 68.2±14.6 | 0.892 | 65.9±18.3 | 68.8±14.7 | 0.112 |
| Male sex | 330(50.8%) | 88(46.8%) | 242(52.5%) | 0.189 | 108(43.4%) | 222(55.5%) | 0.001 | 50(41.3%) | 280(53.0%) | 0.02 |
| NIHSS (median) | 5 | 16 | 3 | n/a | 12 | 3 | 0.000 | 14 | 4 | 0.000 |
| Diabetes | 120(18.5%) | 38(20.2%) | 82(17.8%) | 0.47 | 44(17.7%) | 76(19.0%) | 0.671 | 23(19.0%) | 97(18.4%) | 0.871 |
| CAD | 147(22.7%) | 47(25.0%) | 100(21.7%) | 0.361 | 58(23.3%) | 89(22.3%) | 0.758 | 26(21.5%) | 121(22.9%) | 0.735 |
| Atrial fibrillation | 137 (21.1%) | 59(31.4%) | 78(16.9%) | 0.000 | 75(30.1%) | 62(15.5%) | 0.000 | 36(29.8%) | 101(19.1%) | 0.01 |
| Smoking | 201(31.0%) | 51(27.1%) | 150(32.5%) | 0.176 | 74(29.7%) | 127(31.8%) | 0.586 | 36(29.8%) | 165(31.3%) | 0.748 |
| Hyperlipid | 190(29.3%) | 52(27.7%) | 138(29.9%) | 0.563 | 76(30.5%) | 114(28.5%) | 0.582 | 36(29.8%) | 154(29.2%) | 0.898 |
| IV tPA | 101(15.6%) | 64(34.0%) | 37(8.0%) | 0.000 | 69(27.7%) | 32(8.0%) | 0.000 | 34(28.1%) | 67(12.7%) | 0.000 |
| IA thrombolysis | 31(4.8%) | 29(15.4%) | 2(0.4%) | 0.000 | 31(12.4%) | 0(0.0%) | 0.000 | 12(9.9%) | 19(3.6%) | 0.003 |